Keeping Track: US FDA Clears Another CAR-T And Another Novel ADHD Drug; Submissions Blossom

 
• By Bridget Silverman
Keeping Track Feature image
Abecma is only the second CBER original approval so far this year.

More from Approvals

More from Product Reviews